Nicotinamide treatment robustly protects from inherited mouse glaucoma
Nicotinamide adenine dinucleotide (NAD) is a key molecule in several cellular processes and is essential for healthy mitochondrial metabolism. We recently reported that mitochondrial dysfunction is among the very first changes to occur within retinal ganglion cells during initiation of glaucoma in D...
Main Authors: | Pete A. Williams, Jeffrey M. Harder, Brynn H. Cardozo, Nicole E. Foxworth, Simon W. M. John |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-01-01
|
Series: | Communicative & Integrative Biology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/19420889.2017.1356956 |
Similar Items
-
Nicotinamide and WLDS Act Together to Prevent Neurodegeneration in Glaucoma
by: Simon W. M. John, et al.
Published: (2017-04-01) -
NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve
by: James R. Tribble, et al.
Published: (2023-01-01) -
Molecular mechanisms of retinal ganglion cell degeneration in glaucoma and future prospects for cell body and axonal protection
by: Yasunari eMunemasa, et al.
Published: (2013-01-01) -
Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
by: James R. Tribble, et al.
Published: (2021-02-01) -
Neuroprotection in Glaucoma: NAD<sup>+</sup>/NADH Redox State as a Potential Biomarker and Therapeutic Target
by: Bledi Petriti, et al.
Published: (2021-06-01)